A305-409A-T
- Brand
- Bethyl Laboratories
- Application
- IP
- Storage Conditions
- 2 - 8° C
- Host
- Rabbit
- Conjugation
- Unconjugated
- Immunogen
- between 100 and 150
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide
- Reactivity
- Human
- Target
- FDFT1
- Shelf Life
- 1 year from date of receipt
- Antibody Type
- Polyclonal
- Alternate Names
- DGPT, ERG9, Farnesyl-diphosphate farnesyltransferase, FPP:FPP farnesyltransferase, presqualene-di-diphosphate synthase, SQS, squalene synthase, squalene synthetase, SS
- Format
- Whole IgG
- Presumed Reactivity
- Based on 100% sequence identity, this antibody is predicted to react with Mouse, Bovine and Orangutan
- Product Type
- Primary Antibodies
- Product Sub Types
- Primary Antibodies
- UNSPSC
- 12352203
- Western Blot (WB)
- Not recommended. A305-409A has not performed satisfactorily when used for WB of FDFT1 in crude preparations (e.g. whole cell lysate). This antibody can be used for WB of enriched (e.g. immunoprecipitated) sources of FDFT1.
- Immunoprecipitation (IP)
- 2 - 10 µg/mg lysate
- Target Sentence
- Farnesyl-diphosphate farnesyltransferase 1 (FDFT1) is a membrane-associated enzyme located at a branch point in the mevalonate pathway. FDFT1 is the first specific enzyme in cholesterol biosynthesis, catalyzing the dimerization of two molecules of farnesyl diphosphate in a two-step reaction to form squalene [taken from NCBI Entrez Gene (Gene ID: 2222)].
- Product Link
- http://www.bethyl.com/product/A305-409A